Small G-Protein Rheb Gates Mammalian Target of Rapamycin Signaling to Regulate Morphine Tolerance in Mice.

Wenying Wang,Xiaqing Ma,Wenjie Du,Raozhou Lin,Zhongping Li,Wei Jiang,Lu-Yang Wang,Paul F. Worley,Tao Xu

DOI: https://doi.org/10.1097/aln.0000000000004885

IF: 8.986

2024-01-01

Anesthesiology

Abstract:Background: Analgesic tolerance due to long-term use of morphine remains a challenge for pain management. Morphine acts on mu-opioid receptors and downstream of the phosphatidylinositol 3-kinase signaling pathway to activate the mammalian target of rapamycin (mTOR) pathway. Rheb is an important regulator of growth and cell-cycle progression in the central nervous system owing to its critical role in the activation of mTOR. The hypothesis was that signaling via the GTP-binding protein Rheb in the dorsal horn of the spinal cord is involved in morphine-induced tolerance. Methods: Male and female wild-type C57BL/6J mice or transgenic mice (6 to 8 weeks old) were injected intrathecally with saline or morphine twice daily at 12-h intervals for 5 consecutive days to establish a tolerance model. Analgesia was assessed 60 min later using the tail-flick assay. After 5 days, the spine was harvested for Western blot or immunofluorescence analysis. Results: Chronic morphine administration resulted in the upregulation of spinal Rheb by 4.27 +/- 0.195-fold (P = 0.0036, n = 6), in turn activating mTOR by targeting rapamycin complex 1 (mTORC1). Genetic overexpression of Rheb impaired morphine analgesia, resulting in a tail-flick latency of 4.65 +/- 1.10 s (P < 0.0001, n = 7) in Rheb knock-in mice compared to 10 s in control mice (10 +/- 0 s). Additionally, Rheb overexpression in spinal excitatory neurons led to mTORC1 signaling overactivation. Genetic knockout of Rheb or inhibition of mTORC1 signaling by rapamycin potentiated morphine-induced tolerance (maximum possible effect, 52.60 +/- 9.56% in the morphine + rapamycin group vs. 16.60 +/- 8.54% in the morphine group; P < 0.0001). Moreover, activation of endogenous adenosine 5 '-monophosphate-activated protein kinase inhibited Rheb upregulation and retarded the development of morphine-dependent tolerance (maximum possible effect, 39.51 +/- 7.40% in morphine + metformin group vs. 15.58 +/- 5.79% in morphine group; P < 0.0001). Conclusions: This study suggests spinal Rheb as a key molecular factor for regulating mammalian target of rapamycin signaling.